T17	Exp 150 155	which
T18	Exp 182 204	the tat-I gene product
T19	Exp 358 360	we
T20	Exp 309 330	the NF-kappa B family
T21	Exp 375 388	the abilities
T22	Exp 345 356	this effect
T23	Exp 502 504	We
T24	Exp 516 520	that
T25	Exp 521 553	the p49(100) DNA binding subunit
T26	Exp 617 631	the expression
T27	Exp 770 775	which
T28	Exp 793 809	the HIV enhancer
T29	Exp 813 824	these cells
T30	Exp 849 853	that
T31	Exp 854 869	the combination
T32	Exp 925 947	the tat-I gene product
T33	Exp 961 974	the synthesis
T34	Exp 826 840	These findings
R3	Coref Anaphora:T17 Antecedent:T35
R4	Coref Anaphora:T27 Antecedent:T11
T1	Protein 49 52	Tat
T2	Protein 186 191	tat-I
T3	Protein 434 439	Tat-I
T4	Protein 525 533	p49(100)
T5	Protein 569 572	p65
T6	Protein 598 603	Tat-I
T7	Protein 639 642	CAT
T8	Protein 700 704	p105
T9	Protein 719 722	rel
T10	Protein 744 747	p65
T11	Protein 763 768	c-rel
T12	Protein 873 881	p49(100)
T13	Protein 886 889	p65
T14	Protein 929 934	tat-I
T35	Exp 132 149	a protein complex
